Doheny Asset Management /Ca Karyopharm Therapeutics Inc. Transaction History

Doheny Asset Management /Ca

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 14, 2019	SELL	$4.12 - $10.25 $193,763 - $482,057	-47,030 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$8.2 - $16.95 $1.38 Million - $2.85 Million	-168,415 Reduced 78.17%	47,030 $441,000
Q3 2018 Nov 14, 2018	SELL	$17.03 - $21.18 $1.15 Million - $1.43 Million	-67,500 Reduced 23.86%	215,445 $3.67 Million
Q2 2018 Aug 10, 2018	BUY	$12.0 - $19.88 $647,460 - $1.07 Million	53,955 Added 23.56%	282,945 $4.81 Million
Q1 2018 May 17, 2018	BUY	$9.92 - $17.25 $2.27 Million - $3.95 Million	228,990 New	228,990 $3.07 Million

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $67M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Doheny Asset Management /Ca, based on Form 13F filings with the SEC.

Stay updated on Doheny Asset Management /Ca with notifications on news.